Evaluation of Glutathione peroxidase activity and Angiotensin II as monitoring biomarkers of long-term therapy in Iraqi patients with prostate cancer
Bioactive Compounds in Health and Disease - Online ISSN 2574-0334 Print ISSN 2769-2426 · 13.03.2026 · 9 (3) · 171-180
DOI: 10.31989/bchd.v9i3.1941 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioactive Compounds in Health and Disease - Online ISSN 2574-0334 Print ISSN 2769-2426, online erschienen am 13.03.2026. Verfasst von Wejdan Salman Hashim Wejdan Salman Hashim und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Prostate cancer is the second most common cancer in men worldwide. The current therapeutic approaches include the use of hormonal manipulation, particularly agents like Goserelin acetate and Bicalutamide.
Objective
The present study sought to explore the combination of Goserelin acetate and Bicalutamide therapy on aldosterone, angiotensin II, glutathione, and glutathione peroxidase activity in prostate cancer patients, before treatment and after three years of therapy.
Methods
A total of 100 participants were collected, including 30 prostate cancer patients before treatment (G2), 40 participants were collected after treatment with Goserelin acetate as monotherapy (G4), and 30 participants with Goserelin acetate and Bicalutamide as combine therapy (G5).
Results
The results showed significantly in all parameters when compared to newly diagnosed except GSH in monotherapy. Notably, ROC curve analysis demonstrated an excellent discriminative ability, with an AUC of 0.914 for G4 and 1.000 for G5 in Ang II hormone, also in GSH-Px enzyme activity was 1.000 for group G4 and 0.968 for group G5. This highlighting Ang II and GSH-Px activity as a highly sensitive and specific monitoring biomarker for long-term treatment response assessment.
Conclusion
This study highlights a strong association between alterations in steroid hormones and prostate cancer progression under combination hormonal therapy, suggesting their potential role as biomarkers for monitoring therapeutic efficacy. Novelty of the Study։ This study provides the first comparative evaluation of Glutathione peroxidase activity and Angiotensin II as monitoring biomarkers of long-term therapy in Iraqi patients with prostate cancer. Keywords: Aldosterone, Angiotensin II, Glutathione peroxidase activity, Goserelin acetate, Bicalutamide.
Zitieren
APA
Hashim, W. S. H. W. S., & Al-Issa, Y. (2026). Evaluation of Glutathione peroxidase activity and Angiotensin II as monitoring biomarkers of long-term therapy in Iraqi patients with prostate cancer. Bioactive Compounds in Health and Disease - Online ISSN 2574-0334 Print ISSN 2769-2426, 9(3), 171-180. https://doi.org/10.31989/bchd.v9i3.1941
Vancouver
Hashim WSHWS, Al-Issa Y. Evaluation of Glutathione peroxidase activity and Angiotensin II as monitoring biomarkers of long-term therapy in Iraqi patients with prostate cancer. Bioactive Compounds in Health and Disease - Online ISSN 2574-0334 Print ISSN 2769-2426. 2026;9(3):171-180. doi:10.31989/bchd.v9i3.1941
BibTeX
@article{Hashim2026,
author = {Hashim, Wejdan Salman Hashim Wejdan Salman and Al-Issa, Yasser},
title = {Evaluation of Glutathione peroxidase activity and Angiotensin II as monitoring biomarkers of long-term therapy in Iraqi patients with prostate cancer},
journal = {Bioactive Compounds in Health and Disease - Online ISSN 2574-0334 Print ISSN 2769-2426},
year = {2026},
volume = {9},
number = {3},
pages = {171--180},
doi = {10.31989/bchd.v9i3.1941}
}
EUVIMED